anti stat4 (Cell Signaling Technology Inc)
Structured Review
Anti Stat4, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 130 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stat4/Stat4+Rabbit+mAb/pm41826817-101-59-63
Average 95 stars, based on 130 article reviews
Images
Related Articles
Generated:Article Title: Furamidine enhances IL-23-mediated autophagic response through IL-23R-TYK2-STAT3-dependent regulation of intracellular Ca²⁺ level to facilitate mycobacterial clearance in human macrophages. Article Snippet: Extended author information available on the last page of the article Abstract Mycobacterium tuberculosis (M. tb), the etiological agent of tuberculosis (TB), subverts host immune responses to establish persistent infection by influencing cytokine production.. An effective and balanced cytokine response is crucial for eliminating the pathogen, whereas disruptions in this balance can lead to increased vulnerability to infection.. Therefore, developing immunomodulatory agents to steer host immunity toward the adequate clearance of M. tb offers a promising strategy for limiting TB. other:Article Title: STAT-independent functions of Janus kinases 1 and 2 are obligatory for the postnatal development of mammary epithelial ducts Article Snippet: Rabbit monoclonal, Western Blot:Article Title: Deficiency of osteopontin in gut epithelial cells enhances intestinal integrity by promoting gut renewal through the JAK3/STAT4 pathway in acetaminophen (APAP)-induced acute liver injury. Article Snippet: .. The following primary antibodies were used for western blot analyses: OPN (R&D), Cyp2E1 ACCEPTED MANUSCRIPT AR TIC LE IN PR ES S ARTICLE IN PRESS (Millipore), Staining:Article Title: Inhibition of RBPJ transcription complex promotes IL-17 and IFN-γ secretion by CD4⁺ T cells in hepatocellular carcinoma. Article Snippet: Hepatocellular carcinoma (HCC) is characterized by an immunosuppressive tumor microenvironment (TME), indicating that immune cell activation is a promising approach.. The use of γ-secretase inhibitors (GSIs) to control high Notch signaling activity is currently one of the traditional methods for clinical immunotherapy of HCC.. However, the lack of substrate specificity in GSIs often leads to serious side effects. Inhibition:Article Title: Inhibition of RBPJ transcription complex promotes IL-17 and IFN-γ secretion by CD4⁺ T cells in hepatocellular carcinoma. Article Snippet: Hepatocellular carcinoma (HCC) is characterized by an immunosuppressive tumor microenvironment (TME), indicating that immune cell activation is a promising approach.. The use of γ-secretase inhibitors (GSIs) to control high Notch signaling activity is currently one of the traditional methods for clinical immunotherapy of HCC.. However, the lack of substrate specificity in GSIs often leads to serious side effects. |

